Kidney meridian
KI-23 (Shénfēng, 神封) — Spirit Seal
- Meridian
- Kidney (KI)
- Anatomical view
- anterior
- Point classification
- Regular point of the Kidney channel on the chest.
- Depth reference
- 0.5–0.8 cun transverse or shallow oblique along the chest wall
- Moxibustion
- Not established in checked sources
- Reference aliases
- KI23; Shenfeng; 神封; Spirit Seal
Anatomical location
On the anterior chest, in the fourth intercostal space and 2 cun lateral to the midline.
Traditional actions
Opens the chest; regulates descending Lung qi; benefits breast tissue.
Recorded indications
Primary: Cough; asthma; chest or hypochondriac fullness.
Secondary: Breast nodules in traditional use.
How to read this reference
AcuAtlas separates anatomical location, traditional classification, recorded actions, indications, insertion-depth references, and moxibustion notes because these fields answer different study questions. The location statement is the orientation anchor. The classification and actions describe traditional reference categories, while indications summarize how checked educational sources associate the point with established teaching material. They are not a recommendation to select or stimulate the point.
Depth and moxibustion entries are reproduced as bounded reference notes rather than procedural instructions. Individual anatomy, technique, angle, clinical setting, and local professional standards can change what is appropriate. Review the cited documents and supervised training material before using any technical field. The normalized map coordinate is included only to place the point on the matching AcuAtlas body plate; it is not a substitute for palpation or anatomical assessment.
Sources
References displayed on this page were recorded with the point dataset.
Frequently asked questions
Where is KI-23 located?
On the anterior chest, in the fourth intercostal space and 2 cun lateral to the midline.
What reference actions and indications are recorded for KI-23?
Opens the chest; regulates descending Lung qi; benefits breast tissue. The dataset lists these primary indications: Cough; asthma; chest or hypochondriac fullness. Secondary indications are recorded as: Breast nodules in traditional use.
Is KI-23 safe during pregnancy?
This dataset does not identify KI-23 as one of its five mandatory pregnancy-caution points. That is not a declaration of safety. Pregnancy-related point selection requires individualized assessment by a qualified clinician.